RRP ISA Survey Results

    Avesthagen partners with ShigaMediX to develop vaccines for cervical cancer

    by Maharashtra Mumbai
    4/25/2008, 04/25/08


    India’s leading knowledge based Life Sciences Company, Avesthagen Limited recently signed a Letter of Intent with Paris based ShigaMediX SAS. The partnership will result in developing a novel therapeutic vaccine against HPV (Human Papilloma Virus), which causes cervical cancer.